These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17625483)

  • 1. Illicit drugs, alcohol, and addiction in human immunodeficiency virus.
    Samet JH; Walley AY; Bridden C
    Panminerva Med; 2007 Jun; 49(2):67-77. PubMed ID: 17625483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of use of alcohol and illicit drugs by AIDS patients on adherence to antiretroviral therapy in Bahia, Brazil.
    Teixeira C; Dourado Mde L; Santos MP; Brites C
    AIDS Res Hum Retroviruses; 2013 May; 29(5):799-804. PubMed ID: 23294471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing the risk of HIV infection associated with illicit drug use.
    American Academy of Pediatrics Committee on Pediatric AIDS
    Pediatrics; 2006 Feb; 117(2):566-71. PubMed ID: 16452382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From addiction to infection: managing drug abuse in the context of HIV/AIDS in Africa.
    Akindipe T; Abiodun L; Adebajo S; Lawal R; Rataemane S
    Afr J Reprod Health; 2014 Sep; 18(3 Spec No):47-54. PubMed ID: 26050376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of alcohol and drug relapse prevention in the treatment and prevention of HIV disease.
    Swanson J; Cooper A
    J Int Assoc Physicians AIDS Care; 1998 Apr; 4(4):14-9. PubMed ID: 11365181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between risk behaviors and antiretroviral resistance in HIV-infected patients receiving opioid agonist treatment.
    Tetrault JM; Kozal MJ; Chiarella J; Sullivan LE; Dinh AT; Fiellin DA
    J Addict Med; 2013; 7(2):102-7. PubMed ID: 23388678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing treatment outcomes in HIV-infected patients with substance abuse issues.
    Celentano DD; Lucas G
    Clin Infect Dis; 2007 Dec; 45 Suppl 4():S318-23. PubMed ID: 18190306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health risk behaviors among HIV-infected youth in Bangkok, Thailand.
    Rongkavilit C; Naar-King S; Chuenyam T; Wang B; Wright K; Phanuphak P
    J Adolesc Health; 2007 Apr; 40(4):358.e1-8. PubMed ID: 17367731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of needle exchange programs in HIV prevention.
    Vlahov D; Junge B
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):75-80. PubMed ID: 9722812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of drug abuse and HIV/AIDS in China: recommendations for integrated care of HIV-infected drug users.
    Li X; He G; Wang H; Williams AB
    AIDS Patient Care STDS; 2009 Oct; 23(10):877-84. PubMed ID: 19799494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating HIV prevention into the medical care of persons living with HIV. Recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.
    ; ; ;
    MMWR Recomm Rep; 2003 Jul; 52(RR-12):1-24. PubMed ID: 12875251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance abuse treatment and risk behaviors among HIV-infected persons with alcohol problems.
    Palepu A; Raj A; Horton NJ; Tibbetts N; Meli S; Samet JH
    J Subst Abuse Treat; 2005 Jan; 28(1):3-9. PubMed ID: 15723726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.
    Blair JM; McNaghten AD; Frazier EL; Skarbinski J; Huang P; Heffelfinger JD
    MMWR Surveill Summ; 2011 Sep; 60(11):1-20. PubMed ID: 21881551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: adherence analysis A5084.
    Cohn SE; Umbleja T; Mrus J; Bardeguez AD; Andersen JW; Chesney MA
    AIDS Patient Care STDS; 2008 Jan; 22(1):29-40. PubMed ID: 18442305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV and Substance Use Disorder: Role of the HIV Physician.
    Bositis CM; St Louis J
    Infect Dis Clin North Am; 2019 Sep; 33(3):835-855. PubMed ID: 31255382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy. Public Health Service statement. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Sep; 47(RR-17):1-14. PubMed ID: 9763107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV, alcohol, and noninjection drug use.
    Van Tieu H; Koblin BA
    Curr Opin HIV AIDS; 2009 Jul; 4(4):314-8. PubMed ID: 19532070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV infection among intravenous drug users: epidemiology and risk reduction.
    Des Jarlais DC; Friedman SR
    AIDS; 1987 Jul; 1(2):67-76. PubMed ID: 3130084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV risk reduction in outpatient drug abuse treatment: individual and geographic differences.
    Broome KM; Joe GW; Simpson DD
    AIDS Educ Prev; 1999 Aug; 11(4):293-306. PubMed ID: 10494354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.